171 related articles for article (PubMed ID: 9645940)
21. Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation.
Ali H; Tomhave ED; Richardson RM; Haribabu B; Snyderman R
J Biol Chem; 1996 Feb; 271(6):3200-6. PubMed ID: 8621721
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors.
de Paulis A; Florio G; Prevete N; Triggiani M; Fiorentino I; Genovese A; Marone G
J Immunol; 2002 Oct; 169(8):4559-67. PubMed ID: 12370393
[TBL] [Abstract][Full Text] [Related]
23. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
[TBL] [Abstract][Full Text] [Related]
24. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
25. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
26. High constitutive activity of the human formyl peptide receptor.
Wenzel-Seifert K; Hurt CM; Seifert R
J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
[TBL] [Abstract][Full Text] [Related]
27. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
28. Cross-talk between insulin receptor and integrin alpha5 beta1 signaling pathways.
Guilherme A; Torres K; Czech MP
J Biol Chem; 1998 Sep; 273(36):22899-903. PubMed ID: 9722509
[TBL] [Abstract][Full Text] [Related]
29. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
[TBL] [Abstract][Full Text] [Related]
30. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis.
Perez HD; Kelly E; Elfman F; Armitage G; Winkler J
J Clin Invest; 1991 Mar; 87(3):971-6. PubMed ID: 1999504
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
Feltner DE; Smith RH; Marasco WA
J Immunol; 1986 Sep; 137(6):1961-70. PubMed ID: 3018082
[TBL] [Abstract][Full Text] [Related]
32. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
[TBL] [Abstract][Full Text] [Related]
33. Bacterial formyl peptide mediated chemotaxis and extracellular acidification in shrimp haemocytes.
Yip EC; Wong YH; Wong JT
Dev Comp Immunol; 2001 May; 25(4):269-77. PubMed ID: 11246066
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain.
Tiffany HL; Lavigne MC; Cui YH; Wang JM; Leto TL; Gao JL; Murphy PM
J Biol Chem; 2001 Jun; 276(26):23645-52. PubMed ID: 11316806
[TBL] [Abstract][Full Text] [Related]
35. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
36. Cyclic AMP-increasing agents interfere with chemoattractant-induced respiratory burst in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase rather than receptor-operated Ca2+ influx.
Ahmed MU; Hazeki K; Hazeki O; Katada T; Ui M
J Biol Chem; 1995 Oct; 270(40):23816-22. PubMed ID: 7559558
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
38. Formyl peptide receptor expression in birds.
Panaro MA; Cianciulli A; Lisi S; Sisto M; Acquafredda A; Mitolo V
Immunopharmacol Immunotoxicol; 2007; 29(1):1-16. PubMed ID: 17464763
[TBL] [Abstract][Full Text] [Related]
39. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells.
Viswanathan A; Painter RG; Lanson NA; Wang G
Stem Cells; 2007 May; 25(5):1263-9. PubMed ID: 17234990
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis.
Hsu MH; Chiang SC; Ye RD; Prossnitz ER
J Biol Chem; 1997 Nov; 272(47):29426-9. PubMed ID: 9367998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
